Trials / Completed
CompletedNCT05124821
Evaluation of Performance Over Dwell Time and Safety of the Central-venous Catheters Certofix® Paed
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- B. Braun Melsungen AG · Industry
- Sex
- All
- Age
- 1 Day – 17 Years
- Healthy volunteers
- Not accepted
Summary
Central venous catheterisation is a medical technique that has become established over many decades and can be rated as State of the Art. However, there is only few clinical evidence for the use of Certofix® Paed and additional clinical data need to be collected to underline the long-term performance and safety in paediatric patients. An updated summary overview of Binninger and Roschke describes the potential incidence rates of the classically catheter-related complications, e.g. catheter malposition, catheter fracture, occlusion, thrombosis and catheter-related bloodstream infections (CRBSI) which may have an impact on overall morbidity, mortality and treatment costs. These catheter-related complications should be evaluated in this non-interventional study in paediatric patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Central venous catheter intended to be used for children during routine clinical practice | Device will applied according to instruction for use (IFU) and respective indication during routine clinical practice. |
Timeline
- Start date
- 2023-05-19
- Primary completion
- 2024-04-22
- Completion
- 2024-04-22
- First posted
- 2021-11-18
- Last updated
- 2024-06-13
Locations
3 sites across 2 countries: Germany, Italy
Source: ClinicalTrials.gov record NCT05124821. Inclusion in this directory is not an endorsement.